Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Pediatric Early Rehabilitation in Acute Lymphoblastic Leukemia [NA]
The clinical trial NCT06170385 on pediatric early rehabilitation for acute lymphoblastic leukemia has completed; the snippet does not provid…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: TRacking Atopic Dermatitis Infants and Their Microbiome (TRAM)
A completed clinical trial (TRAM) that tracks the microbiome in infants with atopic dermatitis and pediatric acute lymphoblastic leukemia, s…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell
An observational study of people living with HIV treated with CD19-directed CAR T-cell therapy has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: Reduce Sedentary Time in Acute Lymphoblastic Leukemia [NA]
A clinical trial evaluating reducing sedentary time in children with acute lymphoblastic leukemia has completed. The study was sponsored by …
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies [Phase 1]
A Phase 1 trial evaluating flotetuzumab for relapsed or refractory CD123-positive hematologic malignancies has completed, providing initial …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies [Phase 2, Phase 3]
A Phase 2/3 clinical trial is evaluating co-infusion of regulatory T cell–enriched donor lymphocytes with a CD3-depleted hematopoietic stem …
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Vaccine Immune Recovery After Leukemia
This clinical trial update reports results from a vaccine study aimed at immune recovery after pediatric acute lymphoblastic leukemia. The s…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: MT2017-45: CAR-T Cell Therapy for Heme Malignancies [Phase 2]
Phase 2 trial MT2017-45 CAR-T cell therapy for hematologic malignancies has an active-not-recruiting status with results posted as of 2026-0…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Robot Rehab: AAI With Robot During Inpatient Pediatric Rehab [NA]
This completed clinical trial from the University of Nebraska evaluated robot-assisted rehabilitation integrated with animal-assisted interv…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies
The Orca-T Expanded Access Program study for patients with advanced hematologic malignancies has a status update. The study is temporarily n…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Naïve Undergoing Surgery to Reduce Postoperative Opioid Use (GAMING-ON Study) [Phase 2]
Phase II randomized trial evaluating whether an augmented reality game can reduce postoperative opioid use in pediatric cancer surgery patie…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Influences of High-fiber, Organic Whole-food Formula on the Gut Microbiome in Critically Ill Children [NA]
This clinical trial update reports on a completed study evaluating the impact of a high-fiber, organic whole-food formula on the gut microbi…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL [Phase 1]
Phase 1 trial of CAR-20/19-T cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Optimizing Recovery in Pediatric ALL Survivors: A Training Comparison [NA]
A completed clinical trial comparing training interventions to optimize recovery in pediatric acute lymphoblastic leukemia survivors.
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Study to Investigate Intravenous Blinatumomab in Japanese Adult Participants With Newly Diagnosed Philadelphia-negative B-precursor Acute Lymphoblastic Leukemia (B-ALL) [Phase 1]
This clinical trial update indicates completion of a Phase 1 study of intravenous blinatumomab in Japanese adults with newly diagnosed Phila…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Preliminary Effectiveness and Feasibility of Transcutaneous Acupoints Electrical Stimulation on Chemotherapy-induced Peripheral Neuropathy Among Children With Acute Lymphoblastic Leukemia [NA]
This clinical trial update assesses the preliminary effectiveness and feasibility of transcutaneous acupoints electrical stimulation for che…
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702) [NA]
A completed clinical trial update reporting long-term outcomes of alternative donor allogeneic transplantation across multiple hematologic d…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Besponsa Post Marketing Surveillance Study
A post-marketing surveillance study of Besponsa (inotuzumab ozogamicin) by Pfizer has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia [Phase 1]
Phase Ib trial evaluating subcutaneous blinatumomab in combination with revumenib for KMT2A-rearranged acute lymphoblastic leukemia; the stu…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Validation of the ANI in Perpubescent Patients in Pediatric Intensive Care Unit.
A completed clinical trial validating the Analgesia/Nociception Index (ANI) in prepubescent patients in a pediatric intensive care unit.
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study of inotuzumab ozogamicin in combination chemotherapy for acute lymphoblastic leukemia…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating cytokine-treated veto cells as an adoptive therapy after stem cell transplantation for various hematolog…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) [Phase 1, Phase 2]
The first-in-human study of SAR443579 in children and adults with relapsed or refractory acute myeloid leukemia, acute lymphoblastic leukemi…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: CD22 Redirected Autologous T Cells for ALL [Phase 1]
Phase 1 clinical trial update on autologous T cells redirected to CD22 for B-cell leukemias and lymphomas, sponsored by the University of Pe…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: BESPONSA Injection 1 mg Special Investigation
Completed clinical trial evaluating BESPONSA (inotuzumab ozogamicin) 1 mg for acute lymphoblastic leukemia; results have been posted.